3 results match your criteria: "OH. Electronic address: Megan.Miller6@UHhospitals.org.[Affiliation]"
Should breast surgery be considered for patients with de novo metastatic inflammatory breast cancer?
Am J Surg
July 2024
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA; University Hospitals Research in Surgical Outcomes and Effectiveness (UH-RISES), Cleveland, OH, USA. Electronic address:
Article Synopsis
- Researchers studied women with a serious form of breast cancer called stage IV inflammatory breast cancer to see why some had surgery and others did not.
- They found that only about 29% of the patients had surgery, and being older or treated more recently made women less likely to get surgery.
- The women who had surgery lived longer than those who didn't, so the study suggests more research is needed to figure out which stage IV patients should have surgery.
Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database.
Am J Surg
January 2023
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA; University Hospitals Research in Surgical Outcomes and Effectiveness (UH-RISES), USA. Electronic address:
Background: Despite evidence that early-stage male breast cancer (MBC) can be treated the same as in females, we hypothesized that men undergo more extensive surgery.
Methods: Patients with clinical T1-2 breast cancer were identified in the National Cancer Database 2004-2016. Trends in surgery type and overall survival were compared between sexes.
Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis.
Surgery
September 2022
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; University Hospitals Research in Surgical Outcomes and Effectiveness (UH-RISES), Cleveland, OH. Electronic address:
Background: Race, access to care, and molecular features result in outcome disparities in triple-negative breast cancer (TNBC). We sought to determine the role of age in TNBC disparity by hypothesizing that younger patients receive more comprehensive treatment, resulting in survival differences.
Methods: The National Cancer Database was used to identify women with unilateral TNBC treated from 2005 through 2017.